Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Raimondo

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
The American Journal of Gastroenterology|December 20, 2017
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER StudyS Basili, V Raparelli, L Napoleone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 7, 2008
The use of molecular assays in the management of viral hepatitisA Mangia, F Antonucci, M Brunetto, et al.
Alimentary Pharmacology & Therapeutics|March 30, 2011
IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis CG Fattovich, L Covolo, S Bibert, et al.
Journal of Viral Hepatitis|October 31, 2013
Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysisV Di Marco, L Covolo, V Calvaruso, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 27, 2007
Prophylaxis and treatment of hepatitis B in immunocompromised patientsA Marzano, E Angelucci, P Andreone, et al.
The New England Journal of Medicine|September 4, 2024
BCMA-Targeted T-Cell-Engager Therapy for Autoimmune DiseaseMelanie Hagen, Laura Bucci, Sebastian Böltz, et al.
Italian Journal of Gastroenterology and Hepatology|December 4, 1998
Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre studyA Ascione, M De Luca, C Canestrini, et al.
Alimentary Pharmacology & Therapeutics|August 10, 2017
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre studyG Cabibbo, S Petta, V Calvaruso, et al.
The Lancet. Rheumatology|November 14, 2024
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case seriesJanina Auth, Fabian Müller, Simon Völkl, et al.
Nature Immunology|January 2, 2026
Skin-derived myeloid precursors and joint-resident fibroblasts spread psoriatic disease from skin to jointsMaria G Raimondo, Hashem Mohammadian, Mario R Angeli, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
The American Journal of Gastroenterology|December 20, 2017
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER StudyS Basili, V Raparelli, L Napoleone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 7, 2008
The use of molecular assays in the management of viral hepatitisA Mangia, F Antonucci, M Brunetto, et al.
Alimentary Pharmacology & Therapeutics|March 30, 2011
IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis CG Fattovich, L Covolo, S Bibert, et al.
Journal of Viral Hepatitis|October 31, 2013
Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysisV Di Marco, L Covolo, V Calvaruso, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 27, 2007
Prophylaxis and treatment of hepatitis B in immunocompromised patientsA Marzano, E Angelucci, P Andreone, et al.
The New England Journal of Medicine|September 4, 2024
BCMA-Targeted T-Cell-Engager Therapy for Autoimmune DiseaseMelanie Hagen, Laura Bucci, Sebastian Böltz, et al.
Italian Journal of Gastroenterology and Hepatology|December 4, 1998
Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre studyA Ascione, M De Luca, C Canestrini, et al.
Alimentary Pharmacology & Therapeutics|August 10, 2017
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre studyG Cabibbo, S Petta, V Calvaruso, et al.
The Lancet. Rheumatology|November 14, 2024
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case seriesJanina Auth, Fabian Müller, Simon Völkl, et al.
Nature Immunology|January 2, 2026
Skin-derived myeloid precursors and joint-resident fibroblasts spread psoriatic disease from skin to jointsMaria G Raimondo, Hashem Mohammadian, Mario R Angeli, et al.
Pageof 10